Caterina F.
- Country
- Italy
- Department
- Clinica Dermatologica
Research Overview
- Phase 3 Randomized, Double‑Blind, Placebo‑Controlled Study of Upadacitinib in Adolescents and Adults with Moderate to Severe Atopic Dermatitis
- A Phase 3 Randomized, Placebo-Controlled, Double-Blind Study to Evaluate Upadacitinib in Combination with Topical Corticosteroids in Adolescent and Adult Subjects with Moderate to Severe Atopic Dermatitis
- Long-term Extension Study of Apremilast in Pediatric Patients Aged 6-17 with Moderate to Severe Plaque Psoriasis
Data & Insights
Has run more than one trial at 39 of 132 partner sites.
Specializations
Dermatological Disorders
Specialized in treating moderate to severe atopic dermatitis and plaque psoriasis, with particular focus on developing therapeutic solutions for both adult and pediatric populations.
- Inflammatory Skin Conditions
- Pediatric Dermatology
- Chronic Skin Disorders
Focuses on both standalone treatments and combination therapies with topical corticosteroids.
Age-Specific Therapeutics
Demonstrates expertise in managing dermatological conditions across different age groups, from pediatric patients aged 6-17 to adult populations.
- Adolescent Medicine
- Adult Therapeutics
- Age-Adapted Treatment Protocols
Specializes in developing age-appropriate therapeutic approaches for skin conditions.
Systemic Treatments
Expert in systemic therapy approaches for dermatological conditions, including evaluation of novel therapeutic agents like upadacitinib and apremilast.
- Advanced Therapeutic Options
- Long-term Treatment Strategies
- Combination Therapy Approaches
Focuses on long-term safety and efficacy in chronic skin condition management.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.